[Chemotherapy of advanced ovarian cancer]
- PMID: 2214158
[Chemotherapy of advanced ovarian cancer]
Abstract
Cisplatin containing chemotherapy has provoked an epic making revolution in the treatment of advanced ovarian cancer. However, the impact to the long-term survival is still discouraging. In this article, standard regime for first line chemotherapy, dose, administration method, routes, number of cycles and the second line chemotherapy which is the most embraced problem are described. Strategy for the treatment of advanced ovarian cancer would be continued until the development of new drugs which are effective comparable with cisplatin and have no cross resistance with cisplatin. In order to get significant improvement of 5 year survival, complete response by chemotherapy or complete resection by operation or by both is indispensable and partial response is not sufficient.
Similar articles
-
Medical therapy of advanced malignant epithelial tumours of the ovary.Forum (Genova). 2000 Oct-Dec;10(4):323-32. Forum (Genova). 2000. PMID: 11535983 Review.
-
[Treatment of advanced ovarian cancer].Gan To Kagaku Ryoho. 1990 Sep;17(9):1856-63. Gan To Kagaku Ryoho. 1990. PMID: 2203316 Review. Japanese.
-
Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. doi: 10.1006/gyno.1994.1347. Gynecol Oncol. 1994. PMID: 7835816 Review.
-
[Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].Ai Zheng. 2005 Aug;24(8):1002-5. Ai Zheng. 2005. PMID: 16086882 Chinese.
-
Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-40-S15-43. Semin Oncol. 1997. PMID: 9346221 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical